Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment.
Londres HD, Armada JJ, Martínez AH, Abdo Cuza AA, Sánchez YH, Rodríguez AG, Figueroa SS, Llanez Gregorich EM, Torres Lahera ML, Peire FG, González TM, González YZ, Añé Kouri AL, Palomo AG, Concepción MT, Pérez LM, Luaces-Alvarez PL, Iglesias DE, Hernández DS, Suzarte MR, Ramos TC.
Londres HD, et al. Among authors: hernandez ds.
Immunotherapy. 2022 May;14(7):521-530. doi: 10.2217/imt-2022-0027. Epub 2022 Mar 21.
Immunotherapy. 2022.
PMID: 35306855
Free PMC article.
Clinical Trial.